Patient's perspective: psychological burden of the COVID-19 pandemic in 146 psoriatic patients treated with biological drugs and small molecules in real clinical practice

J Dermatolog Treat. 2022 Mar;33(2):1185-1187. doi: 10.1080/09546634.2020.1790485. Epub 2020 Jul 9.

Authors

A Rodríguez-Villa Lario¹, D Vega-Díez¹, M González-Cañete¹, I Polo-Rodríguez¹, A B Piteiro-Bermejo¹, M Herrero-Fernández², J Arévalo-Serrano³, L Trasobares-Marugán¹, S Medina-Montalvo¹

Affiliations

¹ Department of Dermatology, Príncipe de Asturias University Hospital, Alcalá de Henares, Madrid, Spain.
² Department of Pharmacy, Príncipe de Asturias University Hospital, Alcalá de Henares, Madrid, Spain.
³ Department of Medicine, Príncipe de Asturias University Hospital, Alcalá de Henares, Madrid, Spain.

PMID: 32643475
DOI: 10.1080/09546634.2020.1790485

No abstract available

Publication types

Letter
Comment

MeSH terms

Biological Products* / therapeutic use
COVID-19*
Humans
Pandemics
SARS-CoV-2

Substances

Biological Products